Prelude Therapeutics Reports Full Year 2021 Financial Results

Go back to Prelude Therapeutics Reports Full Year 2021 Financial Results
(NASDAQ: PRLD) Delayed: 6.63 +0.13 (2.00%)
Previous Close $6.50    52 Week High
Open $6.56    52 Week Low
Day High $6.82    P/E N/A 
Day Low $6.40    EPS
Volume 519,207